Rare Disease Clinical Trial Feasibility Tool

Feb 07, 2014
By Applied Clinical Trials Editors
Rare Disease Management (RDM), a clinical development company, based in Wilmington, NC focusing primarily on orphan and rare diseases, announced its rare disease clinical trial feasibility tool that enables pharmaceutical, biotech and CRO clients to best identify the top investigators in orphan and rare diseases. The tool— ExpertSense—was developed by RDM in collaboration with the Technical University of Denmark Bioinformatics team. That team was also responsible for the introduction of FindZebra, a investigator tool that helps give rare disease investigators a hypothesis for rare diseases.
lorem ipsum